You are here

melanoma

Replimune’s melanoma success looks more than skin deep

EP Vantage

Fri, 12/9/22 - 10:34 am

clinical trials

Bristol Myers spells out Opdivo win in melanoma — how does it stack up against Keytruda?

Endpoints

Thu, 10/20/22 - 10:41 am

Bristol Myers Squibb

Merck and Moderna Move Forward with Personalized Cancer Vaccine

BioSpace

Wed, 10/12/22 - 11:35 pm

Moderna Therapeutics

OncoSec sheds 45% of staff to fund IL-12 drug through Keytruda combo trial

Fierce Biotech

Wed, 10/5/22 - 10:31 am

OncoSec Medical

clinical trials

Bristol Myers' Opdivo win tees up showdown with Keytruda in earlier-stage melanoma

Fierce Pharma

Thu, 09/15/22 - 11:15 pm

Bristol Myers Squibb

Sapience receives orphan designation for ST101 to treat advanced melanoma

Pharmaceutical Business Review

Wed, 05/4/22 - 10:23 am

Sapience Therapeutics

What’s next for Bristol Myers' relatlimab?

EP Vantage

Wed, 03/23/22 - 10:36 am

Bristol Myers Squibb

Nektar Left Reassessing After Canceled Melanoma Trials

BioSpace

Tue, 03/15/22 - 11:38 pm

Bristol Myers Squibb

clinical trials

bempegaldesleukin

Idera Pharmaceuticals' stock tanks after AbbVie cuts enrollment early in a PhIb trial

Endpoints

Wed, 12/15/21 - 11:49 pm

Idera Pharmaceuticals

clinical trials

Keytruda wins eighth FDA approval of 2021, moving into adjuvant and pediatric melanoma settings

Endpoints

Mon, 12/6/21 - 10:57 am

BioNTech Bags Fast-Track Status for Melanoma Treatment

BioSpace

Sat, 11/20/21 - 11:56 am

Proscia touts study showing digital pathology software detected melanoma

MedCity News

Thu, 10/14/21 - 11:10 pm

artificial intelligence

BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

Fierce Biotech

Wed, 09/8/21 - 11:24 pm

Merck's Keytruda takes home adjuvant win in melanoma, escalating early-line fight with Bristol Myers

Endpoints

Thu, 08/5/21 - 11:05 am

clinical trials

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma

Benzinga

Fri, 06/18/21 - 10:23 am

clinical trials

Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic

BioPharma Dive

Thu, 06/17/21 - 11:06 am

Sorrento Therapeutics

ASCO 2021 – Alkermes’s disappointment hones melanoma niche focus

EP Vantage

Fri, 06/4/21 - 10:41 am

nemvaleukin alfa

At a Recent Cancer Research Conference, Instil Bio Stole the Show

Motley Fool

Thu, 04/29/21 - 10:30 am

Esmo 2020 – can Alkermes succeed where Nektar failed?

EP Vantage

Wed, 09/23/20 - 10:33 am

OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib

Pharmaceutical Business Review

Tue, 09/22/20 - 11:06 am

Pages